Edwards Lifesciences (EW) PT Raised to $123 at Piper Jaffray

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Edwards Lifesciences (EW) PT Raised to $123 at Piper Jaffray

Edwards Lifesciences Reports First Quarter Results

April 26, 2016 4:15 PM EDT

IRVINE, Calif., April 26, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2016.

First Quarter Highlights:

Sales grew 18.1% to $697.3 million, and underlying1 sales were up 19.7% THVT sales grew 37.0%, and underlying sales were up 38.3% GAAP EPS was $0.66, an increase of 17.9%, and adjusted2 EPS grew 24.6% to $0.71 2016 sales guidance raised to $2.7 - $3.0 billion from $2.6 - $2.85... More